HEADER HYDROLASE 29-SEP-20 7AK1 TITLE HUMAN MALT1(329-729) IN COMPLEX WITH A CHROMANE UREA CONTAINING TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION COMPND 3 PROTEIN 1; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: MALT LYMPHOMA-ASSOCIATED TRANSLOCATION,PARACASPASE; COMPND 6 EC: 3.4.22.-; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MALT1, MLT; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR, COMPLEX, ALLOSTERIC INHIBITOR, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR M.RENATUS REVDAT 3 31-JAN-24 7AK1 1 REMARK REVDAT 2 23-DEC-20 7AK1 1 JRNL REVDAT 1 09-DEC-20 7AK1 0 JRNL AUTH C.PISSOT SOLDERMANN,O.SIMIC,M.RENATUS,P.ERBEL,S.MELKKO, JRNL AUTH 2 M.WARTMANN,M.BIGAUD,A.WEISS,P.MCSHEEHY,R.ENDRES,P.SANTOS, JRNL AUTH 3 J.BLANK,A.SCHUFFENHAUER,G.BOLD,N.BUSCHMANN,T.ZOLLER, JRNL AUTH 4 E.ALTMANN,P.W.MANLEY,I.DIX,E.BUCHDUNGER,J.SCESA,J.QUANCARD, JRNL AUTH 5 A.SCHLAPBACH,F.BORNANCIN,T.RADIMERSKI,C.H.REGNIER JRNL TITL DISCOVERY OF POTENT, HIGHLY SELECTIVE, AND IN VIVO JRNL TITL 2 EFFICACIOUS, ALLOSTERIC MALT1 INHIBITORS BY ITERATIVE JRNL TITL 3 SCAFFOLD MORPHING. JRNL REF J.MED.CHEM. V. 63 14576 2020 JRNL REFN ISSN 0022-2623 JRNL PMID 33252239 JRNL DOI 10.1021/ACS.JMEDCHEM.0C01245 REMARK 2 REMARK 2 RESOLUTION. 2.51 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.51 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.55 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 93.9 REMARK 3 NUMBER OF REFLECTIONS : 13054 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.199 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.265 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 614 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.51 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.53 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.31 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2271 REMARK 3 BIN FREE R VALUE : 0.2537 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 22 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2783 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 33 REMARK 3 SOLVENT ATOMS : 44 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 51.17 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -5.52720 REMARK 3 B22 (A**2) : -6.65300 REMARK 3 B33 (A**2) : 12.18030 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 14.42840 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.320 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.624 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.309 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.671 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.317 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.903 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.847 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2872 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3884 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1019 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 480 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2872 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 366 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2138 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.02 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.00 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.09 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -19.3464 -16.0609 14.4032 REMARK 3 T TENSOR REMARK 3 T11: -0.0859 T22: -0.0439 REMARK 3 T33: -0.0307 T12: 0.0108 REMARK 3 T13: 0.0335 T23: 0.0121 REMARK 3 L TENSOR REMARK 3 L11: 0.7766 L22: 0.3569 REMARK 3 L33: 3.6594 L12: 0.1279 REMARK 3 L13: 1.5954 L23: -0.7084 REMARK 3 S TENSOR REMARK 3 S11: -0.0501 S12: -0.0301 S13: -0.0064 REMARK 3 S21: -0.0301 S22: 0.075 S23: -0.1236 REMARK 3 S31: -0.0064 S32: -0.1236 S33: -0.0249 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7AK1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 30-SEP-20. REMARK 100 THE DEPOSITION ID IS D_1292111449. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-AUG-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00001 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13066 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.507 REMARK 200 RESOLUTION RANGE LOW (A) : 42.547 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.0 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.08900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.51 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.52 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.40 REMARK 200 R MERGE FOR SHELL (I) : 0.61100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: BUSTER REMARK 200 STARTING MODEL: 7AK0 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.64 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.54 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12.2 MG/ML, 25MM HEPES PH7.5, 50MM REMARK 280 NACL, 1MM TCEP, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 45.66000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.16500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 45.66000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 28.16500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 110 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16610 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 325 REMARK 465 PRO A 326 REMARK 465 GLY A 327 REMARK 465 SER A 328 REMARK 465 ASP A 329 REMARK 465 ASN A 330 REMARK 465 LYS A 331 REMARK 465 GLU A 332 REMARK 465 GLN A 333 REMARK 465 THR A 334 REMARK 465 THR A 335 REMARK 465 ASP A 336 REMARK 465 GLN A 337 REMARK 465 ARG A 467 REMARK 465 ASN A 468 REMARK 465 ASP A 469 REMARK 465 TYR A 470 REMARK 465 ASP A 471 REMARK 465 ASP A 472 REMARK 465 THR A 473 REMARK 465 ILE A 474 REMARK 465 PRO A 475 REMARK 465 ILE A 476 REMARK 465 LEU A 477 REMARK 465 ASP A 478 REMARK 465 ALA A 479 REMARK 465 LEU A 480 REMARK 465 LYS A 481 REMARK 465 VAL A 482 REMARK 465 GLN A 494 REMARK 465 GLY A 495 REMARK 465 ALA A 496 REMARK 465 GLU A 497 REMARK 465 ALA A 498 REMARK 465 PHE A 499 REMARK 465 GLU A 500 REMARK 465 ILE A 501 REMARK 465 GLN A 502 REMARK 465 HIS A 503 REMARK 465 SER A 504 REMARK 465 GLY A 505 REMARK 465 LEU A 506 REMARK 465 HIS A 718 REMARK 465 ARG A 719 REMARK 465 GLY A 720 REMARK 465 LEU A 721 REMARK 465 GLY A 722 REMARK 465 ARG A 723 REMARK 465 LYS A 724 REMARK 465 THR A 725 REMARK 465 CYS A 726 REMARK 465 PHE A 727 REMARK 465 GLN A 728 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 466 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 351 -45.46 -134.43 REMARK 500 ASP A 385 76.29 46.38 REMARK 500 GLU A 453 44.83 -107.06 REMARK 500 ASP A 522 48.11 -93.53 REMARK 500 THR A 567 93.92 -47.79 REMARK 500 LEU A 711 -137.04 49.30 REMARK 500 ASP A 716 77.99 60.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue RJH A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MG A 802 DBREF 7AK1 A 329 728 UNP Q9UDY8 MALT1_HUMAN 329 728 SEQADV 7AK1 GLY A 325 UNP Q9UDY8 EXPRESSION TAG SEQADV 7AK1 PRO A 326 UNP Q9UDY8 EXPRESSION TAG SEQADV 7AK1 GLY A 327 UNP Q9UDY8 EXPRESSION TAG SEQADV 7AK1 SER A 328 UNP Q9UDY8 EXPRESSION TAG SEQRES 1 A 404 GLY PRO GLY SER ASP ASN LYS GLU GLN THR THR ASP GLN SEQRES 2 A 404 PRO LEU ALA LYS ASP LYS VAL ALA LEU LEU ILE GLY ASN SEQRES 3 A 404 MET ASN TYR ARG GLU HIS PRO LYS LEU LYS ALA PRO LEU SEQRES 4 A 404 VAL ASP VAL TYR GLU LEU THR ASN LEU LEU ARG GLN LEU SEQRES 5 A 404 ASP PHE LYS VAL VAL SER LEU LEU ASP LEU THR GLU TYR SEQRES 6 A 404 GLU MET ARG ASN ALA VAL ASP GLU PHE LEU LEU LEU LEU SEQRES 7 A 404 ASP LYS GLY VAL TYR GLY LEU LEU TYR TYR ALA GLY HIS SEQRES 8 A 404 GLY TYR GLU ASN PHE GLY ASN SER PHE MET VAL PRO VAL SEQRES 9 A 404 ASP ALA PRO ASN PRO TYR ARG SER GLU ASN CYS LEU CYS SEQRES 10 A 404 VAL GLN ASN ILE LEU LYS LEU MET GLN GLU LYS GLU THR SEQRES 11 A 404 GLY LEU ASN VAL PHE LEU LEU ASP MET CYS ARG LYS ARG SEQRES 12 A 404 ASN ASP TYR ASP ASP THR ILE PRO ILE LEU ASP ALA LEU SEQRES 13 A 404 LYS VAL THR ALA ASN ILE VAL PHE GLY TYR ALA THR CYS SEQRES 14 A 404 GLN GLY ALA GLU ALA PHE GLU ILE GLN HIS SER GLY LEU SEQRES 15 A 404 ALA ASN GLY ILE PHE MET LYS PHE LEU LYS ASP ARG LEU SEQRES 16 A 404 LEU GLU ASP LYS LYS ILE THR VAL LEU LEU ASP GLU VAL SEQRES 17 A 404 ALA GLU ASP MET GLY LYS CYS HIS LEU THR LYS GLY LYS SEQRES 18 A 404 GLN ALA LEU GLU ILE ARG SER SER LEU SER GLU LYS ARG SEQRES 19 A 404 ALA LEU THR ASP PRO ILE GLN GLY THR GLU TYR SER ALA SEQRES 20 A 404 GLU SER LEU VAL ARG ASN LEU GLN TRP ALA LYS ALA HIS SEQRES 21 A 404 GLU LEU PRO GLU SER MET CYS LEU LYS PHE ASP CYS GLY SEQRES 22 A 404 VAL GLN ILE GLN LEU GLY PHE ALA ALA GLU PHE SER ASN SEQRES 23 A 404 VAL MET ILE ILE TYR THR SER ILE VAL TYR LYS PRO PRO SEQRES 24 A 404 GLU ILE ILE MET CYS ASP ALA TYR VAL THR ASP PHE PRO SEQRES 25 A 404 LEU ASP LEU ASP ILE ASP PRO LYS ASP ALA ASN LYS GLY SEQRES 26 A 404 THR PRO GLU GLU THR GLY SER TYR LEU VAL SER LYS ASP SEQRES 27 A 404 LEU PRO LYS HIS CYS LEU TYR THR ARG LEU SER SER LEU SEQRES 28 A 404 GLN LYS LEU LYS GLU HIS LEU VAL PHE THR VAL CYS LEU SEQRES 29 A 404 SER TYR GLN TYR SER GLY LEU GLU ASP THR VAL GLU ASP SEQRES 30 A 404 LYS GLN GLU VAL ASN VAL GLY LYS PRO LEU ILE ALA LYS SEQRES 31 A 404 LEU ASP MET HIS ARG GLY LEU GLY ARG LYS THR CYS PHE SEQRES 32 A 404 GLN HET RJH A 801 32 HET MG A 802 1 HETNAM RJH 1-(3-CHLORANYL-4-METHOXY-PHENYL)-3-[7-[(3~{S})-3- HETNAM 2 RJH (METHOXYMETHYL)MORPHOLIN-4-YL]-2-METHYL-PYRAZOLO[1,5- HETNAM 3 RJH A]PYRIMIDIN-6-YL]UREA HETNAM MG MAGNESIUM ION FORMUL 2 RJH C21 H25 CL N6 O4 FORMUL 3 MG MG 2+ FORMUL 4 HOH *44(H2 O) HELIX 1 AA1 LYS A 360 LEU A 376 1 17 HELIX 2 AA2 THR A 387 LEU A 401 1 15 HELIX 3 AA3 ARG A 435 CYS A 439 5 5 HELIX 4 AA4 VAL A 442 GLN A 450 1 9 HELIX 5 AA5 GLY A 509 ASP A 517 1 9 HELIX 6 AA6 LYS A 524 CYS A 539 1 16 HELIX 7 AA7 SER A 570 ALA A 583 1 14 HELIX 8 AA8 PRO A 636 ASP A 640 5 5 HELIX 9 AA9 THR A 650 GLY A 655 5 6 HELIX 10 AB1 LEU A 658 ASP A 662 5 5 HELIX 11 AB2 SER A 674 LEU A 678 5 5 HELIX 12 AB3 PRO A 710 ASP A 716 5 7 SHEET 1 AA1 5 LYS A 379 LEU A 384 0 SHEET 2 AA1 5 LYS A 343 GLY A 349 1 N LEU A 347 O VAL A 381 SHEET 3 AA1 5 TYR A 407 ASN A 419 1 O TYR A 411 N ILE A 348 SHEET 4 AA1 5 ASN A 422 MET A 425 -1 O ASN A 422 N ASN A 419 SHEET 5 AA1 5 LEU A 440 CYS A 441 -1 O LEU A 440 N MET A 425 SHEET 1 AA2 6 LYS A 379 LEU A 384 0 SHEET 2 AA2 6 LYS A 343 GLY A 349 1 N LEU A 347 O VAL A 381 SHEET 3 AA2 6 TYR A 407 ASN A 419 1 O TYR A 411 N ILE A 348 SHEET 4 AA2 6 LEU A 456 ARG A 465 1 O LEU A 460 N LEU A 410 SHEET 5 AA2 6 ILE A 486 ALA A 491 1 O ALA A 491 N LEU A 461 SHEET 6 AA2 6 LEU A 548 SER A 552 -1 O ARG A 551 N PHE A 488 SHEET 1 AA3 4 MET A 590 LYS A 593 0 SHEET 2 AA3 4 GLN A 599 PHE A 608 -1 O ILE A 600 N LEU A 592 SHEET 3 AA3 4 VAL A 611 TYR A 620 -1 O SER A 617 N GLN A 601 SHEET 4 AA3 4 LEU A 668 LEU A 672 -1 O LEU A 672 N MET A 612 SHEET 1 AA4 3 ILE A 625 THR A 633 0 SHEET 2 AA4 3 VAL A 683 TYR A 692 -1 O CYS A 687 N TYR A 631 SHEET 3 AA4 3 VAL A 699 ASN A 706 -1 O GLN A 703 N VAL A 686 CISPEP 1 ASN A 432 PRO A 433 0 2.89 SITE 1 AC1 15 VAL A 344 ALA A 345 LYS A 379 VAL A 381 SITE 2 AC1 15 LEU A 383 GLU A 390 ASN A 393 ALA A 394 SITE 3 AC1 15 GLU A 397 PHE A 398 LEU A 401 ALA A 583 SITE 4 AC1 15 GLN A 676 LEU A 715 MET A 717 SITE 1 AC2 5 ARG A 392 CYS A 439 LEU A 440 CYS A 441 SITE 2 AC2 5 ASN A 444 CRYST1 91.320 56.330 79.783 90.00 99.77 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010951 0.000000 0.001886 0.00000 SCALE2 0.000000 0.017753 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012718 0.00000